|1.||Heggers, John P: 2 articles (05/2006 - 01/2005)|
|2.||Manesh, Mohammad Jalili: 1 article (09/2015)|
|3.||Zahmatkesh, Mohsen: 1 article (09/2015)|
|4.||Babashahabi, Ronak: 1 article (09/2015)|
|5.||Rohanizadeh, R: 1 article (11/2014)|
|6.||Ghadiri, M: 1 article (11/2014)|
|7.||Chrzanowski, W: 1 article (11/2014)|
|8.||Fagan, Shawn: 1 article (07/2014)|
|9.||Goverman, Jeremy: 1 article (07/2014)|
|10.||Keaney, Tim: 1 article (07/2014)|
05/01/1997 - "The mafenide spray open treatment resulted in a bacteriostatic film permitting eschars to remain uninfected while more superficial burns healed and general status improved, enabling delayed grafting to be effective. "
09/30/2011 - "Histological and clinical studies of wound healing were performed in comparable cases of fresh partial-thickness burns treated with honey dressing or mafenide acetate in two groups of 50 randomly allocated patients. "
01/01/2011 - "The study reported here was undertaken to compare the effect of honey and mafenide acetate on auricular burn in rabbit. "
01/01/1974 - "[Experimental studies on the healing times of burns in relation to various methods of treatment (scab, napaltan, nutritive solution)]."
05/01/1972 - "[Bacteriological and clinical studies of the use of sulfamylon in the treatment of burns]."
|2.||Wounds and Injuries (Trauma)
10/01/1983 - "Mafenide acetate as a 5% solution has a lower osmolarity, and clinical trials with this agent have shown it to be both well accepted by patients and effective in wound preparation. "
07/01/2007 - "In the present study, we assessed the proliferation of planktonic and sessile Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in porcine full-thickness wounds covered for up to 48 h with either saline- or mafenide acetate-loaded DRDC puffs and meshes. "
11/01/2014 - "Furthermore, the degradation of materials and the release profile of mafenide were investigated in simulated wound exudates fluid and antibacterial effectiveness of the eluted mafenide was tested on a range of bacterial species. "
09/30/2011 - "Fifty-two per cent of the mafenide acetate treated wounds showed reparative activity with inflammatory changes by day 7. Reparative activity reached 100% by day 21 with the honey dressing and 84% with mafenide acetate. "
09/30/2011 - "In wounds treated with mafenide acetate, epithelialization occurred by day 7 in 72% of cases and in 84% by day 21. "
09/01/1990 - "Mafenide acetate has superior eschar-penetrating characteristics, making it the agent of choice for early treatment of burn wound sepsis. "
10/01/1973 - "An evaluation of five percent sulfamylon cream in control of experimental burn wound sepsis."
10/01/1972 - "The use of sulfamylon for the control of burn wound sepsis in Thailand."
10/01/1971 - "This may explain the lack of in vivo HPO-mafenide enhancement in burn-wound sepsis where exudates would contain such a mixture. "
08/14/1968 - "Control of experimental and clinical burn wounds sepsis by topical application of sulfamylon compounds."
|4.||Wound Infection (Wound Infections)
01/01/1973 - "[The use of sulfamylon for the prophylaxis and treatment of wound infection]."
01/01/1973 - "[Use of sulfamylon for prevention and treatment of wound infection]."
05/01/2006 - "Whereas Sulfamylon is effective in treatment of burn wound infection, controversy exists regarding its effect on the healing process. "
08/01/1976 - "These were the control (group C); 20% body surface burn (group B); 20% burn, seeded with Pseudomonas aeruginosa (group BI); and burned-infected treated topically with mafenide (alpha-amino-p-toluenesulfonamide) acetate (group BIS), a treatment which controls P, aeruginosa burn-wound infection in humans. "
09/01/1991 - "In circumstances in which contaminated devascularized tissue cannot be excised promptly or adequately, prophylactic topical antibacterial therapy (such as mafenide aqueous spray, which can penetrate through devascularized tissue) may prevent otherwise lethal infection."
09/30/2011 - "Thus, in honey-dressed wounds, early subsidence of acute inflammatory changes, better control of infection, and quicker wound healing were observed, while in mafenide acetate treated wounds a sustained inflammatory reaction was noted even on epithelialization."
07/01/1969 - "Sulfamylon acetate in the treatment of pseudomonas pyocyanea infection of burns."
12/01/2006 - "Thirty ICR mice were enrolled in the study, and the Pseudomonas aeruginosa infection model was reproduced by excision of the full layer of dorsal skin with an area of 1 cm x 1 cm. Then they were randomly divided into C ( control, n = 10, with wet compress of isotonic saline at 3 postinjury hour( PIH) ) , M (with hydropathic compress of 100 g/L mafenide at 3 PIH), A (with wet compress of 1 000 mg/L Cecropin B at 3 PIH) groups. "
07/01/1983 - "To evaluate the usefulness of plasmid pattern analysis as an epidemiologic tool and to determine the mechanism of resistance to silver sulfadiazine and mafenide acetate, silver sulfadiazine-resistant, mafenide acetate-resistant Enterobacter cloacae isolates from a 1976 outbreak of infections in a burn unit (group I) were analyzed retrospectively. "
|1.||Mafenide (Mafenide Acetate)
|2.||antineoplaston A10 (A 10)
|3.||Silver Sulfadiazine (SSD)
|8.||Sodium Hypochlorite (Clorox)
|10.||Amphotericin B (Amphotericin)
|2.||Occlusive Dressings (Occlusive Dressing)
|5.||Skin Transplantation (Skin Grafting)